http://www.w3.org/ns/prov#value | - The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
|